Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Optimal Infusion Rate of Amino Acids in Seriously Ill Patients

NCT01923480 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.

NCT NCT01923480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Optimal Infusion Rate of Amino Acids in Seriously Ill Patients
Lead sponsor
Baxter Healthcare Corporation
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2013
Completion date
December 31, 2014
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parenteral nutrition (no primary condition studied)